Neoplasms
Research News and Information

Sunday, November 08, 2009

Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation.

29 Nov 2009 Model-based projections were shown to be useful for deriving most up-to-date population-based cancer survival estimates. However, the performance of these projections, which can be derived by various approaches, has only been evaluated in very few ... Read more...

Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts.

29 Nov 2009 An inverse association between serum total cholesterol and cancer mortality cast a controversy for cause or result of low cholesterol on cancer risk. Therefore, we examined a total of 33,368 Japanese men and women aged 40-69 years, who were free of ... Read more...

Factors affecting the delivery of family-centered care in pediatric oncology.

29 Nov 2009 BACKGROUND: The provision of family-centered care (FCC) emphasizes a partnership between parents and health-care providers so that families are involved in every aspect of services for their child. Our study examines factors related to parental ... Read more...

Latest indexed articles for 'Neoplasms'

These are the very latest articles for this heading:

• Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation. 29 Nov 2009
• Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. 29 Nov 2009
• Factors affecting the delivery of family-centered care in pediatric oncology. 29 Nov 2009
• Health insurance for survivors of childhood cancer: a pre-existing problem. 29 Nov 2009
• Can you cover me now? 29 Nov 2009
• The Canadian Triage Acuity Scale and oncological emergencies in the emergency department: the puzzle pieces may not fit. 29 Nov 2009
• [Montérégie Comprehensive Cancer Care Centre: integrating nurse navigators in Montérégie's oncology teams: one aspect of implementing the Cancer Control Program--Part 1] 29 Nov 2009
• Supporting children of parents who are dying. 29 Nov 2009
• Aging matters in cancer research. 29 Nov 2009
• The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells. 13 Nov 2009
• The Janus-faced role of ezrin in "linking" cells to either normal or metastatic phenotype. 13 Nov 2009
• Absence of IDH2 codon 172 mutation in common human cancers. 13 Nov 2009
• Computerized utility assessment for cancer decision making: promises and pitfalls. 30 Oct 2009
• Cancer screening behaviors and barriers in Asian Americans. 30 Oct 2009
• Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. 30 Oct 2009
• Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity. 30 Oct 2009
• Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. 30 Oct 2009
• Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. 30 Oct 2009
• Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals. 30 Oct 2009
• ER-Golgi network--a future target for anti-cancer therapy. 30 Oct 2009

See a longer list of these articles.

Technical information about 'Neoplasms'

Definition: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor UI: D009369

Alternative terms: Neoplasms; Neoplasm; Tumors; Tumor; Benign Neoplasms; Neoplasms, Benign; Benign Neoplasm; Neoplasm, Benign; Cancer; Cancers;

Related Mesh Headings: Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Carcinogens; DNA, Neoplasm; Oncogenic Viruses; Precancerous Conditions; RNA, Neoplasm; Pleural Effusion, Malignant; Genes, Tumor Suppressor; Anticarcinogenic Agents;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04;

Online Note: pre-explosion = NEOPLASMS (PX)

History Note: /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977

Technical Notes: avoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING (see note there) but "grading" = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.6+ or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS & its specifics; /genet: consider also GENES, TUMOR SUPPRESSOR /immunol: consider also TUMOR ESCAPE; consider also ANTIGENS, NEOPLASM & ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /nurs = the patient, ONCOLOGIC NURSING = the oncologic specialty; /prev: consider also ANTICARCINOGENIC AGENTS; /radiother = the patient, RADIATION ONCOLOGY = the specialty; consider also BRACHYTHERAPY; /second = NEOPLASM METASTASIS but do not confuse with NEOPLASMS, SECOND PRIMARY; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; Tumor Key: TN Suppl